Asset Details
Do you wish to reserve the book?
Diagnostic tests for urinary tract infections and antimicrobial resistance—a reality check between diagnostic innovation and implementation: a critical narrative review
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Diagnostic tests for urinary tract infections and antimicrobial resistance—a reality check between diagnostic innovation and implementation: a critical narrative review
Do you wish to request the book?
Diagnostic tests for urinary tract infections and antimicrobial resistance—a reality check between diagnostic innovation and implementation: a critical narrative review
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Diagnostic tests for urinary tract infections and antimicrobial resistance—a reality check between diagnostic innovation and implementation: a critical narrative review
2026
Overview
Urinary tract infections (UTIs) are a significant health concern worldwide, leading to substantial health and economic burden and contributing to the rise of antimicrobial resistance (AMR). Although there has been significant advancement in diagnostic technologies starting from conventional dipstick urinalysis to molecular assays and artificial intelligence (AI)-supported platforms, their clinical utility and impact still remain unclear. This is fundamentally due to the systemic barriers that hinder the implementation including cost, policy, and limitations to integrate into frontline healthcare and adoption by insurance agencies. This review focuses on critically reviewing UTI epidemiology, current and emerging diagnostics, and their significance in antimicrobial stewardship. We emphasise that bridging the gap between diagnostic innovation and clinical practice is essential to achieving meaningful milestones in AMR reduction. We are primarily arguing that addressing the policy inertia to diagnostic deployment with stewardship strategies is a crucial step for improving patient healthcare outcomes and preserving antimicrobial efficacy.
Publisher
Frontiers Media SA,Frontiers Media S.A
Subject
Anti-Bacterial Agents - pharmacology
/ Anti-Bacterial Agents - therapeutic use
/ artificial intelligence and UTIs
/ Diagnostic Tests, Routine - methods
/ Humans
/ novel sample collection logistics and rapid diagnostics
/ Review
/ Urinary Tract Infections - diagnosis
/ Urinary Tract Infections - drug therapy
/ Urinary Tract Infections - epidemiology
/ Urinary Tract Infections - microbiology
/ Urine
